K162313

Substantially Equivalent

NuVasive Next Generation NVM5 System

Applicant: Nu Vasive, Incorporated
Product code: PDQ
Advisory panel: Ear, Nose, Throat
Date received: 2016-08-18
Decision date: 2017-03-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.